H King, T Aleksic, P Haluska, VM Macaulay - Cancer treatment reviews, 2014 - Elsevier
IGF-1R inhibitors arrived in the clinic accompanied by optimism based on preclinical activity
of IGF-1R targeting, and recognition that low IGF bioactivity protects from cancer. This was …